Position Details

Position Information

Recruitment/Posting Title
Lymphoma Clinical Scholar, Faculty Physician (Assistant/Associate)

Department
CINJ - Medical Heme Malig

Salary Details
A minimum of $291,000, for assistant professor.

Offer Information

The final salary offer may be determined by several factors, including, but not limited to, the candidate's qualifications, experience, and expertise, and availability of department or grant funds to support the position. We also take into consideration market benchmarks, if and when appropriate, and internal equity to ensure fair compensation relative to the university's broader compensation structure. We are committed to offering competitive and flexible compensation packages to attract and retain top talent.

Benefits

Rutgers provides a comprehensive benefits package to eligible employees. The specific benefits vary based on the position and may include:

• Medical, prescription drug, and dental coverage
• Paid vacation, holidays, and various leave programs
• Competitive retirement benefits, including defined contribution plans and voluntary tax-deferred savings options
• Employee and dependent educational benefits (when applicable)
• Life insurance coverage
• Employee discount programs

Posting Summary

Rutgers Cancer Institute seeks an academically oriented hematologist/oncologist for a clinical research position with a clinical focus in lymphoma, a record of original clinical research, and exceptional clinical skills.Unique opportunities exist for collaborations between clinical enterprise at RWJ Barnabas Health and research programs Rutgers Cancer Institute. Research programs at Rutgers Cancer Institute include Cancer Metabolism and Immunology, Genomic Instability and Cancer Genetics, Cancer Pharmacology, Clinical Investigations and Precision Therapeutics, and Cancer Prevention and Control. There are a broad range of teaching opportunities with medical students, house staff, and fellows. Academic rank and clinical research support commensurate with experience. Uniquely qualified candidates may be considered for additional leadership responsibilities as Section Head for Hematologic Malignancy.

The academic appointment will be within the Rutgers Robert Wood Johnson Medical School and located in New Brunswick, NJ. Faculty members are expected to support the educational goals of the school, engaging in teaching activities for medical students and residents, as well as delivering targeted lectures in their area of expertise.

See all our open faculty positions here!

Position Status
Full Time

Posting Number
25FA0786

Posting Open Date
10/18/2024

Posting Close Date

Qualifications

Minimum Education and Experience

Qualified candidates must have:

• MD/DO/MBBS
• ABIM eligible/certified
• Completed or in progress of completing a 3-year hematology/oncology fellowship
• Have active/be eligible for NJ Medical License

Certifications/Licenses

Required Knowledge, Skills, and Abilities

Preferred Qualifications

Candidates at mid-senior level with experience and expertise in conducting and leading clinical research.

Equipment Utilized

Physical Demands and Work Environment

Overview

RBHS

New Jersey's premier academic health center, Rutgers Biomedical and Health Sciences (RBHS) takes an integrated approach to educating students, providing clinical care, and conducting research, all with the goal of improving human health. Aligned with Rutgers University-New Brunswick and collaborating university wide, RBHS includes eight schools, a behavioral health network, and five centers and institutes that focus on cancer treatment and research, neuroscience, advanced biotechnology and medicine, environmental and occupational health, and health care policy and aging research. Our renowned faculty are teachers, health researchers and providers, and scientists with unparalleled experience who advance medical innovation and provide patient care informed by the latest research findings. We offer an outstanding education and training in medicine, dentistry, pharmacy, public health, nursing, biomedical research, and the full spectrum of allied health careers. An important mission of RBHS is to promote the careers of faculty, staff, and learners. Through this community of healers, scientists, and scholars, Rutgers is equipped as never before to transform lives.

Rutgers Robert Wood Johnson Medical SchoolAs one of the nation's comprehensive medical schools, Rutgers Robert Wood Johnson Medical School (RWJMS) is dedicated to pursuing excellence in education, research, healthcare delivery, and the promotion of community health. In cooperation with Robert Wood Johnson University Hospital, the medical school's principal affiliate, they comprise New Jersey's premier academic medical center. In addition, RWJMS has 34 other hospital affiliates and ambulatory care sites throughout the region. RWJMS encompasses 20 basic science and clinical departments and hosts centers and institutes, described below. The medical school maintains undergraduate, graduate, and postgraduate educational programs for more than 1,500 students on its campuses in New Brunswick and Piscataway. It provides continuing education courses for healthcare professionals and community education programs. Previously an academic unit of the University of Medicine and Dentistry of New Jersey, RWJMS became part of Rutgers, The State University of New Jersey, as part of the New Jersey Medical and Health Sciences Education Restructuring Act, on July 1, 2013.

Rutgers Cancer Institute

As New Jersey's only National Cancer Institute-designated Comprehensive Cancer Center, Rutgers Cancer Institute, in partnership with RWJBarnabas Health, is a leader in cancer research, treatment, prevention, and education. Rutgers Cancer Institute offers world-class cancer care, providing patients with the most advanced treatment options through an integrated cancer care network, including clinical trials, immunotherapy, precision medicine, complex surgical procedures, and sophisticated radiation therapy techniques. Rutgers Cancer Institute and Robert Wood Johnson University Hospital, an RWJBarnabas Health facility, are one of only two programs in the state to offer blood and marrow transplantations and CAR T-cell therapy. It also houses the state's only hospital-based proton therapy center. Rutgers Cancer Institute is a cornerstone of New Jersey's premier academic health center, Rutgers Biomedical and Health Sciences (RBHS).

Construction is currently underway for a new $750 million state-of-the-art Cancer Center adjacent to the current Rutgers Cancer Institute facility and Robert Wood Johnson University Hospital. The 510,000 square foot Jack and Sheryl Morris Cancer Center will be the state's first free-standing cancer hospital. It will feature outpatient and inpatient clinical space-including 84 infusion bays, 74 exam rooms, and 96 inpatient beds. This is in addition to state-of-the-art laboratories where critical scientific investigation will be amplified, enabling physician-scientists to translate findings directly to patients. The Jack and Sheryl Morris Cancer Center will also have the capacity to offer wellness and education resources all in one location. Learn more about this incredible facility at www.cinj.org/jackandsherylmorriscancercenter

Rutgers Cancer Institute is home to nearly 250 internationally recognized physicians and researchers. The long-standing relationship with their NCI Research Consortium Partner Princeton University was recently leveraged to establish the Ludwig Cancer Research Princeton Branch with several faculty as founding members and leaders of the Branch. Their work on cancer metabolism, not only through the new Ludwig Branch but also through the Duncan and Nancy MacMillan Cancer Immunology and Metabolism Center of Excellence at Rutgers Cancer Institute, will accelerate and translate laboratory discoveries into clinical treatments through more effective and efficiently designed clinical trials.

The Rutgers Cancer Institute's Duncan and Nancy MacMillan Cancer Immunology and Metabolism Center of Excellence is an institute at the intersection of oncologic immunology and metabolism that seeks to increase research that leads to new therapies for patients; develop cutting-edge facilities to test new interventions; and facilitate commercial and university collaborations. This includes discovery and production of novel cell therapy constructs via an institutional good manufactory practices (GMP) facility. Visit Center of Excellence in Cancer Immunology and Metabolism.

Division of Blood DisordersThe multidisciplinary team of experts within the Hematologic Malignancies Program combines exceptional expertise, knowledge, and skill with advanced therapies to treat benign and malignant blood disorders in a comprehensive and compassionate environment. Physicians are among the nation's most experienced with expertise in routine, rare and complex hematologic malignancies, treating advanced blood cancers with clinical trials, immunotherapy, and other cellular therapies.

Rutgers Cancer Institute is one of the first programs in the state to offer CAR T-cell therapy and other novel cell therapy constructs. The Program's approach to cancer care offers the full spectrum of therapeutic procedures and advanced treatment options for patients with acute and chronic leukemia, non-Hodgkin lymphoma, Hodgkin lymphoma, multiple myeloma, myelodysplasia, myeloproliferative diseases, and other hematologic malignancies. Rutgers Cancer Institute, in collaboration with Robert Wood Johnson University Hospital, an RWJBarnabas Health facility, is home to one of only two blood and marrow transplant programs in the state and the only one at an NCI-designated Comprehensive Cancer Center. In addition, Rutgers Cancer Institute is recognized as a Center of Excellence by the Myelodysplastic Syndromes (MDS) Foundation in the research, diagnosis, and treatment of MDS disorders.

The Division of Blood Disorders is organized in the Rutgers Robert Wood Johnson Medical School Department of Internal Medicine, and these provide specialized care for patients with complex conditions. Physicians practice in multiple specialized and statewide referral centers and programs. Hematologists/Oncologists and blood and marrow transplanters with significant expertise in various malignant and benign hematologic disorders participate in providing innovative, comprehensive diagnosis and treatment.

Rutgers Cancer Institute is committed to retaining, recruiting, and developing outstanding faculty, staff, and students, including those traditionally underrepresented in medicine in faculty, staff, and student bodies. It aspires to be an agent of progress in advancing equality and justice while improving healthcare access and reducing healthcare disparities. Visit us here.More information on our community here.